CWICX
Price
$75.64
Change
-$1.39 (-1.80%)
Updated
Nov 13 closing price
Net Assets
144.09B
LGCRX
Price
$19.66
Change
-$0.36 (-1.80%)
Updated
Nov 13 closing price
Net Assets
343.66M
Interact to see
Advertisement

CWICX vs LGCRX

Header iconCWICX vs LGCRX Comparison
Open Charts CWICX vs LGCRXBanner chart's image
American Funds Capital World Gr&Inc 529C
Price$75.64
Change-$1.39 (-1.80%)
VolumeN/A
Net Assets144.09B
Lord Abbett Global Equity R3
Price$19.66
Change-$0.36 (-1.80%)
VolumeN/A
Net Assets343.66M
CWICX vs LGCRX Comparison Chart in %
View a ticker or compare two or three
VS
CWICX vs. LGCRX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CWICX is a StrongBuy and LGCRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CWICX has more cash in the bank: 144B vs. LGCRX (344M). CWICX pays higher dividends than LGCRX: CWICX (0.70) vs LGCRX (0.14). CWICX was incepted earlier than LGCRX: CWICX (24 years) vs LGCRX (9 years). LGCRX (1.97) is less costly to investors than CWICX (1.53). LGCRX is a more actively managed with annual turnover of: 41.00 vs. CWICX (27.00). LGCRX has a lower initial minimum investment than CWICX: LGCRX (0) vs CWICX (250). LGCRX annual gain was more profitable for investors over the last year : 18.09 vs. CWICX (14.14). LGCRX (47.19) and CWICX (45.37) have equivalent 5 years return.
CWICXLGCRXCWICX / LGCRX
Total Expense Ratio1.531.15133%
Annual Report Gross Expense Ratio1.531.9778%
Fund Existence24 years9 years-
Gain YTD22.59621.186107%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets144B344M41,860%
Annual Yield % from dividends0.700.14512%
Returns for 1 year14.1418.0978%
Returns for 3 years53.4870.9875%
Returns for 5 years45.3747.1996%
Returns for 10 years94.28N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EVEX4.530.12
+2.72%
Eve Holding
EPRX6.600.07
+1.07%
Eupraxia Pharmaceuticals
CGCTU10.30N/A
N/A
Cartesian Growth Corp III
CFR124.27-0.67
-0.54%
Cullen/Frost Bankers
MVO4.34-0.04
-0.91%
MV Oil Trust